U.S. Government Moves To Participate In ‘Skinny Label’ High Court Arguments
WASHINGTON, D.C. — The United States government on Feb. 25 filed a motion to participate in oral arguments before the U.S. Supreme Court when it considers arguments from a bioequivalent pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article